跳至主要内容
临床试验/NCT00553709
NCT00553709终止2 期

The Role of Transcutaneous Nicotine in the Prevention of Postoperative Nausea and Vomiting in Non-smokers

University Hospital, Geneva1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
200
试验地点
1
主要终点
Prevention of PONV

研究概览

简要总结

The purpose of this study is to determine whether nicotine is effective in the prevention of nausea and vomiting in non-smokers undergoing surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (18-80 years)
  • ASA I-II, non-smokers (or ex-smokers who have not been smoking for more than 2 years)
  • Undergoing elective surgery (ENT, abdominal, urological, gynaecological); and
  • Consenting to take part in the study will be included.

排除标准

  • Smokers (cigarette, pipe, cigar)
  • Patients undergoing nicotine replacement therapy
  • Prolonged postoperative intubation
  • Postoperative nasogastric tube

研究组 & 干预措施

Nicotine patch

Experimental

Nicotinell® Patch 10 cm2, containing 17.5 mg of nicotine, with an average delivery rate of 7 mg of nicotine per 24 hours (= TTS 10)

干预措施: Nicotine (Drug)

Placebo patch

Placebo Comparator

Placebo patch 10 cm2

干预措施: Nicotine (Drug)

结局指标

主要结局

Prevention of PONV

时间窗: 48 hours postoperatively

次要结局

  • Adverse effects that may be related to the nicotine patch, for instance, local skin reaction.(48 hours postoperatively)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验